Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2009 3
2010 2
2011 5
2012 3
2013 3
2016 4
2017 4
2018 7
2019 7
2020 1
2021 5
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
[Clinical features of five cases of acquired factor V deficiency].
Sei M, Mizuguchi M, Yagi H, Kagawa K, Sekimoto E, Shibata H, Shigekiyo T, Ozaki S. Sei M, et al. Among authors: kagawa k. Rinsho Ketsueki. 2022;63(7):733-739. doi: 10.11406/rinketsu.63.733. Rinsho Ketsueki. 2022. PMID: 35922940 Japanese.
Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity.
Fujii S, Nakamura S, Oda A, Miki H, Tenshin H, Teramachi J, Hiasa M, Bat-Erdene A, Maeda Y, Oura M, Takahashi M, Iwasa M, Endo I, Yoshida S, Aihara KI, Kurahashi K, Harada T, Kagawa K, Nakao M, Sano S, Abe M. Fujii S, et al. Among authors: kagawa k. Br J Haematol. 2018 Jan;180(2):246-258. doi: 10.1111/bjh.15033. Br J Haematol. 2018. PMID: 29327347 Free article.
Effective impairment of myeloma cells and their progenitors by hyperthermia.
Miki H, Nakamura S, Oda A, Tenshin H, Teramachi J, Hiasa M, Bat-Erdene A, Maeda Y, Oura M, Takahashi M, Iwasa M, Harada T, Fujii S, Kurahashi K, Yoshida S, Kagawa K, Endo I, Aihara K, Ikuo M, Itoh K, Hayashi K, Nakamura M, Abe M. Miki H, et al. Among authors: kagawa k. Oncotarget. 2017 Dec 7;9(12):10307-10316. doi: 10.18632/oncotarget.23121. eCollection 2018 Feb 13. Oncotarget. 2017. PMID: 29535808 Free PMC article.
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
Harada T, Ohguchi H, Oda A, Nakao M, Teramachi J, Hiasa M, Sumitani R, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Sano S, Hideshima T, Abe M. Harada T, et al. Among authors: kagawa k. Blood Adv. 2023 Mar 28;7(6):1019-1032. doi: 10.1182/bloodadvances.2022007155. Blood Adv. 2023. PMID: 36129197 Free PMC article.
Allogeneic haematopoietic stem cell transplantation and patient falls: impact of lower extremity muscle strength.
Kondo S, Inoue T, Saito T, Kawamura Y, Katayama A, Nakamura M, Sumitani R, Takahashi M, Oura M, Sogabe K, Harada T, Fujii S, Nakamura S, Miki H, Kagawa K, Sato N, Ono R, Abe M, Katoh S. Kondo S, et al. Among authors: kagawa k. BMJ Support Palliat Care. 2022 May 9:bmjspcare-2022-003582. doi: 10.1136/bmjspcare-2022-003582. Online ahead of print. BMJ Support Palliat Care. 2022. PMID: 35534187
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
Teramachi J, Hiasa M, Oda A, Harada T, Nakamura S, Amachi R, Tenshin H, Iwasa M, Fujii S, Kagawa K, Miki H, Kurahashi K, Yoshida S, Endo I, Haneji T, Matsumoto T, Abe M. Teramachi J, et al. Among authors: kagawa k. Br J Haematol. 2018 Feb;180(4):581-585. doi: 10.1111/bjh.14388. Epub 2016 Oct 17. Br J Haematol. 2018. PMID: 27748523 Free article. No abstract available.
[Analysis of long-term survivors with cardiac AL amyloidosis].
Kagawa K, Maeda Y, Oura M, Sogabe K, Fujino H, Takahashi M, Maruhashi T, Iwasa M, Udaka K, Harada T, Ise T, Fujii S, Nakamura S, Miki H, Yagi S, Takeuchi K, Ozaki S, Abe M. Kagawa K, et al. Rinsho Ketsueki. 2017;58(11):2197-2204. doi: 10.11406/rinketsu.58.2197. Rinsho Ketsueki. 2017. PMID: 29212969 Japanese.
54 results